Novel markers of osteogenic and adipogenic differentiation of human bone marrow stromal cells identified using a quantitative proteomics approach

Stem Cell Research

Volumn 12, Issue 1, 2014, Pages 153-165

  Granéli, Cecilia ^a,b   Thorfve, Anna ^a,b   Ruetschi, Ulla ^a   Brisby, Helena ^a,b   Thomsen, Peter ^a,b   Lindahl, Anders ^a,b   Karlsson, Camilla ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b BIOMATCELL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALPHA CRYSTALLIN; ALPHA5 INTEGRIN; AMINO ACID; ANNEXIN A11; BIOLOGICAL MARKER; CALPHOBINDIN II; CD146 ANTIGEN; CD92 ANTIGEN; CD97 ANTIGEN; CHOLINE TRANSPORTER LIKE PROTEIN 1; COFILIN 1; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; EPOXIDE HYDROLASE 1 PRECURSOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN SUBUNIT GAMMA 5 PRECURSOR; HEAT SHOCK PROTEIN BETA 1; LIPID PHOSPHATE PHOSPHOHYDROLASE 3; LIPOCORTIN 1; LIPOCORTIN 2; LIPOCORTIN 4; LIPOCORTIN 5; MEMBRANE METALLOENDOPEPTIDASE; MEMBRANE PROTEIN; MICROSOMAL AMINOPEPTIDASE; MYOSIN 1C; PEPTIDYLPROLYL ISOMERASE A; PROFILIN I; PROTEIN 14 3 3; PROTEIN S100 A11; UNCLASSIFIED DRUG;

ADIPOGENESIS; ARTICLE; BONE MARROW STROMAL CELL; CELL DIFFERENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MASS SPECTROMETRY; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; STROMA CELL;

ADIPOGENESIS; ALPHA-CRYSTALLIN B CHAIN; ANTIGENS, CD; BIOLOGICAL MARKERS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; ISOTOPE LABELING; MESENCHYMAL STROMAL CELLS; NEPRILYSIN; ORGANIC CATION TRANSPORT PROTEINS; OSTEOGENESIS; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84887540400     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.09.009     Document Type: Article

References (51)

1. Abdallah B.M., Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther. 2007, 15:109-116.
2. Alves R.D.A.M., Eijken M., Swagemakers S., Chiba H., Titulaer M.K., Burgers P.C., Luider T.M., van Leeuwen J.P.T.M. Proteomic analysis of human osteoblastic cells: relevant proteins and functional categories for differentiation. J. Proteome Res. 2010, 9:4688-4700.
3. Arvidson K., Abdallah B.M., Applegate L.A., Baldini N., Cenni E., Gomez-Barrena E., Granchi D., Kassem M., Konttinen Y.T., Mustafa K., Pioletti D.P., Sillat T., Finne-Wistrand A. Bone regeneration and stem cells. J. Cell. Mol. Med. 2011, 15:718-746.
4. Aubin J.E. Regulation of osteoblast formation and function. Rev. Endocr. Metab. Disord. 2001, 2:81-94.
5. Baksh D., Yao R., Tuan R.S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007, 25:1384-1392.
6. Barry F.P., Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int. J. Biochem. Cell Biol. 2004, 36:568-584.
7. Becker M., Siems W.-E., Kluge R., Gembardt F., Schultheiss H.-P., Schirner M., Walther T. New function for an old enzyme: NEP deficient mice develop late-onset obesity. PLoS ONE 2010, 5:e12793.
8. Bianco P., Cao X., Frenette P.S., Mao J.J., Robey P.G., Simmons P.J., Wang C.-Y. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat. Med. 2013, 19:35-42.
9. Caplan A.I., Bruder S.P. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol. Med. 2001, 7:259-264.
10. Chang Y.-J., Shih D.T.-B., Tseng C.-P., Hsieh T.-B., Lee D.-C., Hwang S.-M. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells 2006, 24:679-685.
11. Chang C.B., Han S.A., Kim E.M., Lee S., Seong S.C., Lee M.C. Chondrogenic potentials of human synovium-derived cells sorted by specific surface markers. Osteoarthritis Cartilage 2013, 21:190-199.
12. Chen L., Fink T., Zhang X.-Y., Ebbesen P., Zachar V. Quantitative transcriptional profiling of ATDC5 mouse progenitor cells during chondrogenesis. Differentiation 2005, 73:350-363.
13. Cox J.J., Mann M.M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008, 26:1367-1372.
14. Cox J., Matic I., Hilger M., Nagaraj N., Selbach M. A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics. Nat. Protoc. 2009, 4:698-705.
15. Deng Z.-L., Sharff K.A., Tang N., Song W.-X., Luo J., Luo X., Chen J., Bennett E., Reid R., Manning D., Xue A., Montag A.G., Luu H.H., Haydon R.C., He T.-C. Regulation of osteogenic differentiation during skeletal development. Front. Biosci. 2008, 13:2001-2021.
16. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., Lempicki R.A. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003, 4:P3.
17. Diaz-Romero J., Gaillard J.P., Grogan S.P., Nesic D., Trub T., Mainil-Varlet P. Immunophenotypic analysis of human articular chondrocytes: changes in surface markers associated with cell expansion in monolayer culture. J. Cell. Physiol. 2004, 202:731-742.
18. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D., Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
19. Ducy P., Schinke T., Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000, 289:1501-1504.
20. Forsman A., Rüetschi U., Ekholm J., Rymo L. Identification of intracellular proteins associated with the EBV-encoded nuclear antigen 5 using an efficient TAP procedure and FT-ICR mass spectrometry. J. Proteome Res. 2008, 7:2309-2319.
21. Fort P.E., Lampi K.J. New focus on alpha-crystallins in retinal neurodegenerative diseases. Exp. Eye Res. 2011, 92:98-103.
22. Foster L.J., Zeemann P.A., Li C., Mann M., Jensen O.N., Kassem M. Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation. Stem Cells 2005, 23:1367-1377.
23. Furushima K., Shimo-Onoda K., Maeda S., Nobukuni T., Ikari K., Koga H., Komiya S., Nakajima T., Harata S., Inoue I. Large-scale screening for candidate genes of ossification of the posterior longitudinal ligament of the spine. J. Bone Miner. Res. 2002, 17:128-137.
24. Gronthos S., Franklin D.M., Leddy H.A., Robey P.G., Storms R.W., Gimble J.M. Surface protein characterization of human adipose tissue-derived stromal cells. J. Cell. Physiol. 2001, 189:54-63.
25. Hamidouche Z., Fromigué O., Ringe J., Häupl T., Vaudin P., Pagès J.-C., Srouji S., Livne E., Marie P.J. Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis. Proc. Natl. Acad. Sci. 2009, 106:18587-18591.
26. Hamidouche Z., Fromigué O., Ringe J., Häupl T., Marie P.J. Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation. BMC Cell Biol. 2010, 11:44.
27. Han B., Tang B., Nimni M.E. Combined effects of phosphatidylcholine and demineralized bone matrix on bone induction. Connect. Tissue Res. 2003, 44:160-166.
28. Jones E.A., Kinsey S.E., English A., Jones R.A., Straszynski L., Meredith D.M., Markham A.F., Jack A., Emery P., McGonagle D. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum. 2002, 46:3349-3360.
29. Kern S., Eichler H., Stoeve J., Klüter H., Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006, 24:1294-1301.
30. Kim J.-S., Lee H.-K., Kim M.-R., Kim P.-K., Kim C.-W. Differentially expressed proteins of mesenchymal stem cells derived from human cord blood (hUCB) during osteogenic differentiation. Biosci. Biotechnol. Biochem. 2008, 72:2309-2317.
31. Kim S., Min W.-K., Chun S., Lee W., Chung H.-J., Choi S.J., Yang S.E., Yang Y.S., Yoo J.-I. Protein expression profiles during osteogenic differentiation of mesenchymal stem cells derived from human umbilical cord blood. Tohoku J. Exp. Med. 2010, 221:141-150.
32. Klemenz R., Fröhli E., Steiger R.H., Schäfer R., Aoyama A. Alpha B-crystallin is a small heat shock protein. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:3652-3656.
33. Komori T. Regulation of osteoblast differentiation by transcription factors. J. Cell. Biochem. 2006, 99:1233-1239.
34. Kratchmarova I., Blagoev B., Haack-Sorensen M., Kassem M., Mann M. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 2005, 308:1472-1477.
35. Kulterer B., Friedl G., Jandrositz A., Sanchez-Cabo F., Prokesch A., Paar C., Scheideler M., Windhager R., Preisegger K.-H., Trajanoski Z. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics 2007, 8:70.
36. Lambrecht S., Verbruggen G., Elewaut D., Deforce D. Differential expression of αB-crystallin and evidence of its role as a mediator of matrix gene expression in osteoarthritis. Arthritis Rheum. 2009, 60:179-188.
37. Lv G. Expression and clinical significance of extracellular matrix metalloproteinase inducer, EMMPRIN/CD147, in human osteosarcoma. Oncol. Lett. 2013, 5:201-207.
38. Maguer-Satta V., Besançon R., Bachelard-Cascales E. Concise review: neutral endopeptidase (CD10): a multifaceted environment actor in stem cells, physiological mechanisms, and cancer. Stem Cells 2011, 29:389-396.
39. Mann M. Functional and quantitative proteomics using SILAC. Nat. Rev. Mol. Cell Biol. 2006, 7:952-958.
40. Marom R., Shur I., Solomon R., Benayahu D. Characterization of adhesion and differentiation markers of osteogenic marrow stromal cells. J. Cell. Physiol. 2004, 202:41-48.
41. Michel V., Bakovic M. The solute carrier 44A1 is a mitochondrial protein and mediates choline transport. FASEB J. 2009, 23:2749-2758.
42. Nakamura T., Fujiwara R., Ishiguro N., Oyabu M., Nakanishi T., Shirasaka Y., Maeda T., Tamai I. Involvement of choline transporter-like proteins, CTL1 and CTL2, in glucocorticoid-induced acceleration of phosphatidylcholine synthesis via increased choline uptake. Biol. Pharm. Bull. 2010, 33:691-696.
43. Niehage C., Steenblock C., Pursche T., Bornhäuser M., Corbeil D., Hoflack B. The cell surface proteome of human mesenchymal stromal cells. PLoS ONE 2011, 6:e20399.
44. Nishimura R., Hata K., Ikeda F., Ichida F., Shimoyama A., Matsubara T., Wada M., Amano K., Yoneda T. Signal transduction and transcriptional regulation during mesenchymal cell differentiation. J. Bone Miner. Metab. 2008, 26:203-212.
45. Ong S.-E., Mann M. A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat. Protoc. 2006, 1:2650-2660.
46. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
47. Ruchon A.F., Marcinkiewicz M., Ellefsen K., Basak A., Aubin J., Crine P., Boileau G. Cellular localization of neprilysin in mouse bone tissue and putative role in hydrolysis of osteogenic peptides. J. Bone Miner. Res. 2000, 15:1266-1274.
48. Tokunaga A., Oya T., Ishii Y., Motomura H., Nakamura C., Ishizawa S., Fujimori T., Nabeshima Y.-I., Umezawa A., Kanamori M., Kimura T., Sasahara M. PDGF receptor β is a potent regulator of mesenchymal stromal cell function. J. Bone Miner. Res. 2008, 23:1519-1528.
49. Wang H., Hung S., Peng S., Huang C., Wei H., Guo Y., Fu Y., Lai M., Chen C. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004, 22:1330-1337.
50. Wang L., Tran I., Seshareddy K., Weiss M.L., Detamore M.S. A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering. Tissue Eng. Part A 2009, 15:2259-2266.
51. Zhang A.-X., Yu W.-H., Ma B.-F., Yu X.-B., Mao F.F., Liu W., Zhang J.-Q., Zhang X.-M., Li S.-N., Li M.-T., Lahn B.T., Xiang A.P. Proteomic identification of differently expressed proteins responsible for osteoblast differentiation from human mesenchymal stem cells. Mol. Cell. Biochem. 2007, 304:167-179.